Proposals On EU-Wide Joint Clinical Assessments Fall Short, Warn German Industry Groups
Executive Summary
The German pharmaceutical industry is calling for “directional correction” to the way implementation of the EU’s Health Technology Assessment Regulation is being developed.
You may also be interested in...
European HTA Network Rejects Industry Criticism Of Joint Clinical Assessments
EUnetHTA 21, the EU health technology assessment network that will soon hang up its hat has defended the methodologies it developed to support the EU HTA Regulation in the wake of criticism from industry.
Direction Of Travel Of EU HTA Regulation Is ‘Disappointing’ For Advanced Therapies
Without further work, the EU-wide joint clinical assessments introduced by the EU regulation on health technology assessments will fail to meet the needs of advanced therapies, warns the Alliance for Regenerative Medicine.
The Implications Of The New EU HTA Regulation For Companies
Legal and industry expert Alexander Natz sets out key questions and answers to help companies prepare for new EU regulations on health technology assessments, one of the biggest developments to affect the pharmaceutical industry in over a decade.